"Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally" Study
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Age - Related Macular Degeneration
- Retinal Drusen
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 50 years and 125 years
- Gender
- Both males and females
Description
SAVE Study (Stop Early Age-related Macular Degeneration form Vision Loss Eternally)
SAVE Study (Stop Early Age-related Macular Degeneration form Vision Loss Eternally)
Tracking Information
- NCT #
- NCT02960828
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Kyu Hyung Park, M.D., Ph.D. Seoul National University Bundang Hospital
Get Well Soon